Rigel Pharmaceuticals ROE 2010-2024 | RIGL

Current and historical return on equity (ROE) values for Rigel Pharmaceuticals (RIGL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Rigel Pharmaceuticals ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $0.02B $0.00B -91.89%
2024-09-30 $0.00B $-0.02B -15.09%
2024-06-30 $-0.01B $-0.03B 45.53%
2024-03-31 $-0.02B $-0.03B 66.12%
2023-12-31 $-0.03B $-0.03B 92.04%
2023-09-30 $-0.03B $-0.03B 106.12%
2023-06-30 $-0.04B $-0.03B 181.40%
2023-03-31 $-0.05B $-0.02B 290.32%
2022-12-31 $-0.06B $-0.01B 748.39%
2022-09-30 $-0.08B $-0.02B -2523.08%
2022-06-30 $-0.08B $0.00B -404.82%
2022-03-31 $-0.09B $0.01B -219.35%
2021-12-31 $-0.02B $0.03B -31.86%
2021-09-30 $-0.01B $0.05B -24.35%
2021-06-30 $-0.01B $0.07B -12.12%
2021-03-31 $-0.01B $0.08B -19.47%
2020-12-31 $-0.03B $0.03B -53.10%
2020-09-30 $-0.03B $0.05B -45.53%
2020-06-30 $-0.03B $0.06B -37.88%
2020-03-31 $-0.03B $0.08B -40.14%
2019-12-31 $-0.07B $0.05B -90.54%
2019-09-30 $-0.05B $0.07B -53.41%
2019-06-30 $-0.06B $0.08B -62.18%
2019-03-31 $-0.07B $0.10B -60.19%
2018-12-31 $-0.07B $0.11B -68.11%
2018-09-30 $-0.10B $0.10B -98.04%
2018-06-30 $-0.09B $0.12B -104.16%
2018-03-31 $-0.09B $0.08B -113.36%
2017-12-31 $-0.08B $0.10B -100.32%
2017-09-30 $-0.07B $0.06B -102.64%
2017-06-30 $-0.07B $0.07B -106.18%
2017-03-31 $-0.07B $0.08B -97.49%
2016-12-31 $-0.07B $0.06B -103.70%
2016-09-30 $-0.07B $0.07B -87.58%
2016-06-30 $-0.05B $0.07B -60.71%
2016-03-31 $-0.05B $0.08B -56.20%
2015-12-31 $-0.05B $0.09B -52.00%
2015-09-30 $-0.06B $0.10B -55.84%
2015-06-30 $-0.08B $0.10B -61.48%
2015-03-31 $-0.09B $0.11B -62.21%
2014-12-31 $-0.09B $0.13B -57.23%
2014-09-30 $-0.09B $0.15B -47.95%
2014-06-30 $-0.09B $0.17B -44.84%
2014-03-31 $-0.09B $0.19B -39.81%
2013-12-31 $-0.09B $0.21B -38.26%
2013-09-30 $-0.10B $0.22B -38.36%
2013-06-30 $-0.10B $0.25B -40.66%
2013-03-31 $-0.10B $0.27B -43.68%
2012-12-31 $-0.10B $0.29B -44.70%
2012-09-30 $-0.10B $0.18B -48.06%
2012-06-30 $-0.09B $0.20B -40.57%
2012-03-31 $-0.09B $0.22B -35.77%
2011-12-31 $-0.09B $0.24B -37.55%
2011-09-30 $-0.08B $0.26B -36.41%
2011-06-30 $-0.01B $0.27B -4.69%
2011-03-31 $0.04B $0.15B 25.24%
2010-12-31 $0.04B $0.17B 27.05%
2010-09-30 $0.03B $0.18B 23.72%
2010-06-30 $-0.05B $0.12B -41.14%
2010-03-31 $-0.10B $0.09B -108.05%
2009-12-31 $-0.11B $0.11B -121.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.327B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.901B 31.10
Zoetis (ZTS) United States $68.972B 25.73
Daiichi Sankyo, - (DSNKY) Japan $43.624B 22.19
Takeda Pharmaceutical (TAK) Japan $43.624B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.765B 0.00
Merck (MKKGY) Germany $17.939B 14.85
Summit Therapeutics (SMMT) United States $16.896B 0.00
United Therapeutics (UTHR) United States $13.518B 11.96
Shionogi (SGIOY) Japan $12.590B 12.61
Neurocrine Biosciences (NBIX) United States $11.755B 40.26
IPSEN (IPSEY) France $9.548B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.512B 61.07
Stevanato Group S.p.A (STVN) Italy $7.183B 43.93
Madrigal Pharmaceuticals (MDGL) United States $6.280B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.205B 0.00
Ionis Pharmaceuticals (IONS) United States $5.189B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.702B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.930B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 10.00
Hypermarcas (HYPMY) Brazil $2.687B 17.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.278B 12.46
BioCryst Pharmaceuticals (BCRX) United States $2.061B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.752B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.639B 0.00
Guardian Pharmacy Services (GRDN) United States $1.527B 0.00
Indivior (INDV) United States $1.521B 6.45
Evotec AG (EVO) Germany $1.449B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
ARS Pharmaceuticals (SPRY) United States $1.188B 0.00
Ocular Therapeutix (OCUL) United States $1.104B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.061B 21.22
Enliven Therapeutics (ELVN) United States $0.976B 0.00
Collegium Pharmaceutical (COLL) United States $0.934B 5.04
Harrow (HROW) United States $0.922B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.824B 0.00
Cronos Group (CRON) Canada $0.794B 0.00
Ardelyx (ARDX) United States $0.785B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
AleAnna (ANNA) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.643B 0.00
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Regulus Therapeutics (RGLS) United States $0.543B 0.00
CytoDyn (CYDY) United States $0.532B 0.00
Bioventus (BVS) United States $0.523B 13.29
Savara (SVRA) United States $0.517B 0.00
Relay Therapeutics (RLAY) United States $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.471B 0.00
Altimmune (ALT) United States $0.462B 0.00
Zevra Therapeutics (ZVRA) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.424B 8.85
Theravance Biopharma (TBPH) Cayman Islands $0.421B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Oruka Therapeutics (ORKA) United States $0.364B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.29
Heron Therapeutics (HRTX) United States $0.262B 0.00
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.221B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.183B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.162B 0.00
Inhibikase Therapeutics (IKT) United States $0.158B 0.00
4D Molecular Therapeutics (FDMT) United States $0.145B 0.00
Esperion Therapeutics (ESPR) United States $0.145B 0.00
Journey Medical (DERM) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.130B 0.00
Wellgistics Health (WGRX) United States $0.129B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Profound Medical (PROF) Canada $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.115B 0.00
Larimar Therapeutics (LRMR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.105B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.089B 14.70
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Telomir Pharmaceuticals (TELO) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Context Therapeutics (CNTX) United States $0.071B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Surrozen (SRZN) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Incannex Healthcare (IXHL) Australia $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00